Efficacy of Colesevelam in Subjects With Type 1 Diabetes Mellitus

Trial Profile

Efficacy of Colesevelam in Subjects With Type 1 Diabetes Mellitus

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Aug 2017

At a glance

  • Drugs Colesevelam (Primary)
  • Indications Hyperlipidaemia; Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 29 Jun 2010 Pharmacodynamic outcomes were reported at the 70th Annual Scientific Sessions of the American Diabetes Association.
    • 01 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top